Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Thomas William Flaig

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Flaig, Thomas

One or more keywords matched the following items that are connected to Flaig, Thomas

Item Type	Name
Academic Article	Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma.
Academic Article	Axitinib, a new therapeutic option in renal cell carcinoma.
Academic Article	Tivozanib: practical implications for renal cell carcinoma and other solid tumors.
Academic Article	Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Academic Article	High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Academic Article	Recurrent urothelial carcinoma with pulmonary metastasis.
Academic Article	Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Academic Article	Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.
Academic Article	Thyroid dysfunction in patients treated with sunitinib or sorafenib.
Academic Article	Targeted therapy in advanced urothelial carcinoma.
Academic Article	A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer.
Concept	Carcinoma, Non-Small-Cell Lung
Concept	Carcinoma, Basal Cell
Concept	Carcinoma, Papillary
Concept	Carcinoma
Concept	Carcinoma, Hepatocellular
Concept	Carcinoma, Renal Cell
Concept	Carcinoma, Squamous Cell
Concept	Carcinoma, Transitional Cell
Concept	Carcinoma, Medullary
Academic Article	Skin cancer associated with the use of sorafenib and sunitinib for renal cell carcinoma.
Academic Article	Collision renal cell papillary and medullary carcinoma in a 66-year-old man.
Academic Article	A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
Academic Article	Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study.
Academic Article	Micropapillary bladder cancer: current treatment patterns and review of the literature.
Academic Article	Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
Academic Article	Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.
Academic Article	Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy.
Academic Article	Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).
Academic Article	Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Academic Article	The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma.
Academic Article	Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.
Academic Article	Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?
Academic Article	Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Academic Article	Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.
Academic Article	Renal cell carcinoma: a review of biology and pathophysiology.
Academic Article	The Changing Treatment Landscape for Metastatic Urothelial Carcinoma.
Academic Article	EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma.
Academic Article	Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
Academic Article	National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.
Academic Article	Tumor flare of brain metastases upon dose interruption of sunitinib in a patient with metastatic renal cell carcinoma.
Academic Article	Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).
Academic Article	Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly.
Academic Article	NCCN Guidelines? Insights: Bladder Cancer, Version 2.2022.
Academic Article	A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
Academic Article	Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma.
Academic Article	Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.
Academic Article	A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Academic Article	Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.

Search Criteria

Carcinoma